Treatment with atezolizumab, bevacizumab, paclitaxel, and carboplatin (ABCP) was significantly more effective than pemetrexed plus carboplatin or cisplatin
Good news from the ATTLAS trial for pa... - Lung Cancer Support
Good news from the ATTLAS trial for patients with EGFR mutations and ALK translocations.
Written by
Denzie
Moderator
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
EGFR mutations on exon 20 and exon 21
I have EGFR S768I (exon 20) and EGFR L858R (exon 21) mutations.
Is it normal to have more than one...
Good news - Stage IIIB
good news. I have had clear scan results today after being diagnosed with Stage IIIB, non small...
FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression
immunotherapy option for NSCLC gives patients more options for first line treatments than ever...